Hostname: page-component-89b8bd64d-4ws75 Total loading time: 0 Render date: 2026-05-08T11:20:22.589Z Has data issue: false hasContentIssue false

Protein O- and C-Glycosylation pathways in Toxoplasma gondii and Plasmodium falciparum

Published online by Cambridge University Press:  18 February 2019

Giulia Bandini
Affiliation:
Department of Molecular and Cell Biology, Boston University, Goldman School of Dental Medicine, 72 East Concord Street, Boston, MA 02118, USA
Andreia Albuquerque-Wendt
Affiliation:
Department of Clinical Biochemistry OE4340, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
Jan Hegermann
Affiliation:
Hannover Medical School, Electron Microscopy Facility OE8840, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
John Samuelson
Affiliation:
Department of Molecular and Cell Biology, Boston University, Goldman School of Dental Medicine, 72 East Concord Street, Boston, MA 02118, USA
Françoise H. Routier*
Affiliation:
Department of Clinical Biochemistry OE4340, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
*
Author for correspondence: Françoise H. Routier, E-mail: Routier.Francoise@mh-hannover.de

Abstract

Apicomplexan parasites are amongst the most prevalent and morbidity-causing pathogens worldwide. They are responsible for severe diseases in humans and livestock and are thus of great public health and economic importance. Until the sequencing of apicomplexan genomes at the beginning of this century, the occurrence of N- and O-glycoproteins in these parasites was much debated. The synthesis of rudimentary and divergent N-glycans due to lineage-specific gene loss is now well established and has been recently reviewed. Here, we will focus on recent studies that clarified classical O-glycosylation pathways and described new nucleocytosolic glycosylations in Toxoplasma gondii, the causative agents of toxoplasmosis. We will also review the glycosylation of proteins containing thrombospondin type 1 repeats by O-fucosylation and C-mannosylation, newly discovered in Toxoplasma and the malaria parasite Plasmodium falciparum. The functional significance of these post-translational modifications has only started to emerge, but the evidence points towards roles for these protein glycosylation pathways in tissue cyst wall rigidity and persistence in the host, oxygen sensing, and stability of proteins involved in host invasion.

Information

Type
Review Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Cambridge University Press 2019
Figure 0

Fig. 1. Mucin-type O-glycosylation in T. gondii. (A) Model for mucin-type glycosylation in tachyzoites and bradyzoites. Mucin domains are modified with GalNAc in a hierarchical manner by the activity of pp-GalNAcT2, followed by pp-GalNAcT1 and T3. The activity of these enzymes is dependent of the import of UDP-GalNAc in the Golgi by TgNST1. The resulting structures are recognized by Vicia villosa lectin (VVL) and the anti-Tn antibody. A still unknown glycosyltransferase is believed to transfer a second GalNAc residue, leading to the GalNAcα1,3GalNAc epitope recognized by Dolichos Biflorus agglutinin (DBA). (B) Candidate O-glycosylated proteins have been identified by lectin enrichment in tachyzoites. They localize to secretory organelles found at the apical end of the parasite (as shown by the electron micrograph and the schematic), the inner membrane complex, or the parasitophorous vacuole. Rhoptries, r; conoid, c; inner membrane complex, dark arrow. Subpellicular microtubules are shown in gray in the schematic but are not visible in the micrograph. (C) Bradyzoites are surrounded by a glycan-rich cyst wall containing the proteins CST1 and SRS13. Both proteins contain a mucin domain with Thr-rich repeats extensively modified by O-linked GalNAc glycans. Glycosylation of CST1 confers rigidity to the cyst wall.

Figure 1

Fig. 2. Nucleocytosolic glycosylation pathways in T. gondii. (A) Skp1 glycosylation pathway. Proline 154 of the Skp1 protein is first hydroxylated by TgPhyA and then modified by a pentasaccharide of the composition Galα1,3Glcα1,3Fucα1,2Galβ1,3GlcNAcα1– which is assembled by four glycosyltransferases. Transfer of αGlcNAc to the hydroxylated proline by TgGnt1 is followed by the sequential transfer of β1,3-linked Gal and α1,2Fuc by the bifunctional enzyme TgPgtA. TgGlt1 and TgGat1 transfer the remaining two sugars, Glc and Gal, both in α1,3 linkage. (B) Nucleocytosolic O-fucosylation. TgSPY, a paralogue of animal O-GlcNAc transferases, modifies more than 60 proteins with one or more O-linked fucose residues. Structured illumination microscopy of tachyzoites suggests that the O-fucosylated proteins form assemblies that localize at the nuclear periphery. AAL: Aleuria aurantia lectin (binds to fucose); IMC3: marker for T. gondii inner membrane complex.

Figure 2

Fig. 3. O-fucosylation and C-mannosylation on TSR repeats. (A) Summary of the mass spectrometry evidence for TSR glycosylation in the two parasites. The presence of a plus sign between Glc and Fuc indicates that glycopeptides were observed for two different glycoforms: only dHex (Fuc) or Hex-dHex (FucGlc). (B) Schematic representation of the two TSR glycosylation pathways in T. gondii. DPY19 transfers Man from dolichol-phosphate-mannose to tryptophan (W) residues on TSRs. POFUT2, a soluble protein in most eukaryotes, modifies Ser/Thr in the CX2−3S/TCX2G motif with Fuc, which can be further elongated by addition of Glc by B3GLCT. This glycosylation requires the GDP-Fuc transporter NST2 and a UDP-Glc transporter. (C) In P. falciparum, POFUT2 and DPY19 are known to modify TSRs with O-Fuc and C-Man, as detailed for Toxoplasma. The identities of the B3GLCT and the Hex transferred on Fuc have not yet been ascertained. NST2 is the predicted GDP-Fuc transporter.

Figure 3

Fig. 4. O- and C-glycosylation pathways in Toxoplasma gondii life cycle. T. gondii replicates asexually in the intermediate host with tachyzoites as the fast replicative form and bradyzoites in tissue cysts characterizing the chronic stage of infection. In felids, its definite host, T. gondii goes through a sexual cycle that concludes with the shedding of unsporulated oocysts that then sporulate in the environment. As shown in the schematic, all the glycosylation pathways reviewed here have been shown to be present in tachyzoites. Transfer of O-GalNAc to mucin-like domains is an important post-translational modification in tissue cyst wall proteins and pp-GalNAcT5 is expressed in oocysts. Nuclear O-fucosylation has been shown to be present also in bradyzoites and sporozoites, but is absent from oocysts.

Figure 4

Fig. 5. O- and C-glycosylation pathways in Plasmodium falciparum life cycle. During a mosquito blood meal, sporozoites are injected in the bloodstream and infect the liver. After asexual replication in hepatocytes, the parasites are released into the bloodstream where they replicate in erythrocytes to give the characteristic fever symptoms. A fraction of the parasites will develop into gametocytes that can be transmitted to the mosquito during a blood meal. After zygote formation, Plasmodium ookinetes infect the mosquito midgut and develop into oocysts. Sporozoites are released from the oocysts and travel to the salivary gland ready for a new infection cycle. O-fucosylation and C-mannosylation of TSRs have been demonstrated in sporozoites, but POFUT2 and DPY-19 have been detected in the asexual blood stages. DPY19 is also present in gametocytes. Studies on GDP-Fuc biosynthesis have been performed in the intraerythrocytic stages.